Cardiology - MedEd On The Go

17-32 of 61

MinuteCE®
Differentiating First-Line Treatment Selection: Combination Immunotherapy and Chemotherapy Regimens for Metastatic ESCC
Harry Yoon, MD; Jaffer Ajani, MD
0.75 credits 7 episodes
- Harry Yoon, MD
- Jaffer Ajani, MD
0.75 credits 7 episodes
The Impact of First-Line Treatment on Subsequent Treatment Options for Metastatic ESCC
The Impact of First-Line Treatment on Subsequent Treatment Options for Metastatic ESCC
MinuteCE®
The Impact of First-Line Treatment on Subsequent Treatment Options for Metastatic ESCC
Harry Yoon, MD; Jaffer Ajani, MD
0.75 program credits
- Harry Yoon, MD
- Jaffer Ajani, MD
0.75 program credits
ICI Combination Regimens for First-Line Treatment of Metastatic ESCC
ICI Combination Regimens for First-Line Treatment of Metastatic ESCC
MinuteCE®
ICI Combination Regimens for First-Line Treatment of Metastatic ESCC
Harry Yoon, MD; Jaffer Ajani, MD
0.75 program credits
- Harry Yoon, MD
- Jaffer Ajani, MD
0.75 program credits
Strategies for Navigating First-Line Treatment Selection in Metastatic ESCC
Strategies for Navigating First-Line Treatment Selection in Metastatic ESCC
MinuteCE®
Strategies for Navigating First-Line Treatment Selection in Metastatic ESCC
Harry Yoon, MD; Jaffer Ajani, MD
0.75 program credits
- Harry Yoon, MD
- Jaffer Ajani, MD
0.75 program credits
Effective Monitoring and Management of Adverse Effects in Metastatic ESCC
Effective Monitoring and Management of Adverse Effects in Metastatic ESCC
MinuteCE®
Effective Monitoring and Management of Adverse Effects in Metastatic ESCC
Harry Yoon, MD; Jaffer Ajani, MD
0.75 program credits
- Harry Yoon, MD
- Jaffer Ajani, MD
0.75 program credits
Patient Case Study: Elderly
Patient Case Study: Elderly
MinuteCE®
Patient Case Study: Elderly
Renato D. Lopes, MD, MHS, PhD; Valeria Caso, MD, PhD
1.00 program credit
- Renato D. Lopes, MD, MHS, PhD
- Valeria Caso, MD, PhD
1.00 program credit
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: VTE Considerations
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: VTE Considerations
MinuteCE®
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: VTE Considerations
Alexander T. Cohen, MD, MBBS
1.00 program credit
- Alexander T. Cohen, MD, MBBS
1.00 program credit
Patient Case Study: Obesity
Patient Case Study: Obesity
MinuteCE®
Patient Case Study: Obesity
Renato D. Lopes, MD, MHS, PhD; Valeria Caso, MD, PhD
1.00 program credit
- Renato D. Lopes, MD, MHS, PhD
- Valeria Caso, MD, PhD
1.00 program credit
Patient Case Study: Obesity and VTE
Patient Case Study: Obesity and VTE
MinuteCE®
Patient Case Study: Obesity and VTE
Renato D. Lopes, MD, MHS, PhD; Alexander T. Cohen, MD, MBBS
1.00 program credit
- Renato D. Lopes, MD, MHS, PhD
- Alexander T. Cohen, MD, MBBS
1.00 program credit
Patient Case Study: Cancer-Associated Thrombosis
Patient Case Study: Cancer-Associated Thrombosis
MinuteCE®
Patient Case Study: Cancer-Associated Thrombosis
Renato D. Lopes, MD, MHS, PhD; Alexander T. Cohen, MD, MBBS
1.00 program credit
- Renato D. Lopes, MD, MHS, PhD
- Alexander T. Cohen, MD, MBBS
1.00 program credit
How Do We Translate Real-World AF Data Into Everyday Clinical Practice?
How Do We Translate Real-World AF Data Into Everyday Clinical Practice?
MinuteCE®
How Do We Translate Real-World AF Data Into Everyday Clinical Practice?
Renato D. Lopes, MD, MHS, PhD; Valeria Caso, MD, PhD
1.00 program credit
- Renato D. Lopes, MD, MHS, PhD
- Valeria Caso, MD, PhD
1.00 program credit
How Do We Translate Real-World VTE Data Into Everyday Clinical Practice for Ongoing Anticoagulation?
How Do We Translate Real-World VTE Data Into Everyday Clinical Practice for Ongoing Anticoagulation?
MinuteCE®
How Do We Translate Real-World VTE Data Into Everyday Clinical Practice for Ongoing Anticoagulation?
Alexander T. Cohen, MD, MBBS
1.00 program credit
- Alexander T. Cohen, MD, MBBS
1.00 program credit
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: AF Considerations
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: AF Considerations
MinuteCE®
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: AF Considerations
Valeria Caso, MD, PhD
1.00 program credit
- Valeria Caso, MD, PhD
1.00 program credit
Trade off: Ischemic/Thrombotic vs Bleeding  
Trade off: Ischemic/Thrombotic vs Bleeding  
MinuteCE®
Trade off: Ischemic/Thrombotic vs Bleeding  
Renato D. Lopes, MD, MHS, PhD
1.00 program credit
- Renato D. Lopes, MD, MHS, PhD
1.00 program credit
Setting the Stage of Real-World Data vs RCT
Setting the Stage of Real-World Data vs RCT
MinuteCE®
Setting the Stage of Real-World Data vs RCT
Renato D. Lopes, MD, MHS, PhD
1.00 program credit
- Renato D. Lopes, MD, MHS, PhD
1.00 program credit
MinuteCE®
AF and VTE: Global Considerations in the Evolving Space of Real-World Data
Renato D. Lopes, MD, MHS, PhD; Valeria Caso, MD, PhD
1.00 credit 10 episodes
- Renato D. Lopes, MD, MHS, PhD
- Valeria Caso, MD, PhD
- Alexander T. Cohen, MD, MBBS
1.00 credit 10 episodes

2/4